Point72 (Difc) LTD Biotechnology

Point72 (Difc) LTD

$2.64 Trillion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
INMB Inmune Bio, Inc.	$43.4M	$4.9 Million 0.0% of portfolio	2,120	Q2 2025 New
THRD Third Harmonic Bio, Inc.	$217M	$4.83 Million 0.0% of portfolio	890	Q2 2025 Added 985.37%
ANNX Annexon, Inc.	$116M	$4.71 Million 0.0% of portfolio	1,964	Q2 2025 New
CABA Cabaletta Bio, Inc.	$38.6M	$3.7 Million 0.0% of portfolio	2,432	Q2 2025 New
TRVI Trevi Therapeutics, Inc.	$428M	$2.52 Million 0.0% of portfolio	461	Q2 2025 New
KMPH Kempharm, Inc	$170M	$2.33 Million 0.0% of portfolio	264	Q2 2025 New
FHTX Foghorn Therapeutics Inc.	$203M	$2.26 Million 0.0% of portfolio	481	Q2 2025 Added 27.93%
YMAB Y M Abs Therapeutics, Inc.	$372M	$1.29 Million 0.0% of portfolio	287	Q2 2025 Reduced 94.33%
MDGL Madrigal Pharmaceuticals, Inc.	$6.14B	$1.13 Million 0.0% of portfolio	4	Q2 2025 New
IPSC Century Therapeutics, Inc.	$30.6M	$977,000 0.0% of portfolio	1,749	Q2 2025 New
STTK Shattuck Labs, Inc.	$32.2M	$863,000 0.0% of portfolio	1,090	Q2 2025 New
VRDN Viridian Therapeutics, Inc.\De	$717M	$761,000 0.0% of portfolio	54	Q2 2025 Reduced 98.87%
CADL Candel Therapeutics, Inc.	$183M	$740,000 0.0% of portfolio	146	Q2 2025 New
SEER Seer, Inc.	$129M	$710,000 0.0% of portfolio	332	Q2 2025 Reduced 19.42%
ENOB Enochian Biosciences Inc	$244M	$683,000 0.0% of portfolio	2,365	Q2 2025 New
SGMO Sangamo Therapeutics, Inc	$81.4M	$646,000 0.0% of portfolio	1,194	Q2 2025 Reduced 95.14%
NAUT Nautilus Biotechnology, Inc.	$88.5M	$572,000 0.0% of portfolio	789	Q2 2025 New
ELYM Eliem Therapeutics, Inc.	$109M	$522,000 0.0% of portfolio	421	Q2 2025 New
GBIO Generation Bio Co.	$239M	$463,000 0.0% of portfolio	1,446	Q2 2025 New
TNYA Tenaya Therapeutics, Inc.	$31.4M	$462,000 0.0% of portfolio	756	Q2 2025 Reduced 93.14%
HOWL Werewolf Therapeutics, Inc.	$35.4M	$439,000 0.0% of portfolio	403	Q2 2025 New
IGMS Igm Biosciences, Inc.	$37.7M	$435,000 0.0% of portfolio	388	Q2 2025 Reduced 54.03%
OVID Ovid Therapeutics Inc.	$38.7M	$429,000 0.0% of portfolio	1,301	Q2 2025 New
GALT Galectin Therapeutics Inc	$224M	$395,000 0.0% of portfolio	187	Q2 2025 New
MGNX Macrogenics Inc	$90.3M	$230,000 0.0% of portfolio	190	Q2 2025 New
PDSB Pds Biotechnology Corp	$35M	$66,000 0.0% of portfolio	50	Q2 2025 New
DSGN Design Therapeutics, Inc.	$278M	$66,000 0.0% of portfolio	20	Q2 2025 New
IMRX Immuneering Corp	$85.8M	$54,000 0.0% of portfolio	16	Q2 2025 New
VIGL Vigil Neuroscience, Inc.	$228M	$47,000 0.0% of portfolio	6	Q2 2025 Reduced 14.29%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.